We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

279 hedge funds and large institutions have $2.75B invested in GW Pharmaceuticals Plc American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 64 increasing their positions, 83 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

14% more capital invested

Capital invested by funds: $2.41B → $2.75B (+$344M)

5% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 42

0% more funds holding

Funds holding: 279 → 279 (0)

18% less call options, than puts

Call options by funds: $99.2M | Put options by funds: $121M

23% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 83

Holders
279
Holders Change
–
Holders Change %
0%
% of All Funds
4.94%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
44
Increased
64
Reduced
83
Closed
42
Calls
$99.2M
Puts
$121M
Net Calls
-$21.8M
Net Calls Change
-$5.89M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$91.4M
2
EMG
ETF Managers Group
New Jersey
+$27.6M
3
Renaissance Technologies
Renaissance Technologies
New York
+$7.73M
4
BCM
Brown Capital Management
Maryland
+$7.57M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$3.74M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$52.8M
2
Franklin Resources
Franklin Resources
California
-$34.6M
3
EAM
Eventide Asset Management
Massachusetts
-$25.8M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$15.5M
5
GPP
Great Point Partners
Connecticut
-$14.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFA
251
Professional Financial Advisors
Nebraska
$3K – – –
VRM
252
Vectors Research Management
New York
$3K – – –
CAAS
253
Capital Asset Advisory Services
Michigan
$3K +$3.36K +30 New
BCWM
254
Bartlett & Co Wealth Management
Ohio
$2.31K +$2.24K +20 New
CCM
255
Covington Capital Management
California
$2K – – –
GRP
256
Global Retirement Partners
California
$2K – – –
ME
257
McIlrath & Eck
Washington
$2K – – –
MFA
258
McClarren Financial Advisors
Pennsylvania
$2K +$2.02K +18 New
BC
259
Bartlett & Co
Ohio
$2K +$2.24K +20 New
AFG
260
Albion Financial Group
Utah
$2K +$2.35K +21 New
BSSFA
261
Baron Silver Stevens Financial Advisors
Florida
$2K +$2.46K +22 New
KFS
262
Kelly Financial Services
Massachusetts
$1.96K – – –
PA
263
Parallel Advisors
California
$1K -$2.58K -23 -77%
CHC
264
City Holding Co
West Virginia
$1K – – –
GI
265
Gradient Investments
Minnesota
$1K – – –
PP
266
Pacifica Partners
Canada
$1K – – –
WAS
267
Winch Advisory Services
Wisconsin
$1K – – –
HR
268
Howe & Rusling
New York
$1K +$672 +6 New
PA
269
Perennial Advisors
New York
$1K +$1.34K +12 New
Point72 Asset Management
270
Point72 Asset Management
Connecticut
– -$52.8M -542,164 Closed
N
271
Nuveen
North Carolina
– -$9.03M -92,786 Closed
WP
272
Woodline Partners
California
– -$8.8M -90,435 Closed
PCM
273
Portolan Capital Management
Massachusetts
– -$4.58M -47,091 Closed
RGI
274
River Global Investors
United Kingdom
– -$3.56M -36,500 Closed
WMSA
275
Weiss Multi-Strategy Advisers
New York
– -$1.98M -20,319 Closed
9 10
11
12 13

GWPH Hedge Fund Activity: Q4 2020 in Review

279 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2020, worth a combined $2.75B — up 14% from $2.41B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new GWPH positions and 42 closed out — a net gain of 2 holders — while 64 added to existing stakes and 83 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $91.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $52.8M sold.

  • 279 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $2.75B of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2020, up 14% quarter-over-quarter.
  • 44 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2020 and 42 closed out, a net change of +2 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2020 was Redmile Group, an estimated $91.4M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2020 was Point72 Asset Management, an estimated $52.8M sold.

Based on aggregated 13F filings for Q4 2020.